DongKook Pharmaceutical Co (XKRX:086450) Marketable Securities : ₩33,608 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is DongKook Pharmaceutical Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. DongKook Pharmaceutical Co's Marketable Securities for the quarter that ended in Dec. 2023 was ₩33,608 Mil.

DongKook Pharmaceutical Co's annual Marketable Securities declined from Dec. 2021 (₩84,486 Mil) to Dec. 2022 (₩33,411 Mil) but then increased from Dec. 2022 (₩33,411 Mil) to Dec. 2023 (₩33,608 Mil).

DongKook Pharmaceutical Co Marketable Securities Historical Data

The historical data trend for DongKook Pharmaceutical Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DongKook Pharmaceutical Co Marketable Securities Chart

DongKook Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

84,439.16

121,753.69

84,485.53

33,411.27

33,607.60

DongKook Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Marketable Securities	Get a 7-Day Free Trial															33,411.27	65,036.01	65,887.39	33,022.32	33,607.60

DongKook Pharmaceutical Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

DongKook Pharmaceutical Co (XKRX:086450) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

DongKook Pharmaceutical Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of DongKook Pharmaceutical Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

DongKook Pharmaceutical Co (XKRX:086450) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DongKook Pharmaceutical Co Ltd (XKRX:086450) » Definitions » Marketable Securities

Traded in Other Exchanges

N/A

Address

Dongkook Building 997-8 Daechi 3-dong, Kangnam-gu, Seoul, KOR, 135-502

Website

http://www.dkpharm.co.kr

DongKook Pharmaceutical Co Ltd is a part of the healthcare industry based in Korea. Being a pharmaceutical company, its activities are focused on the research and development of drugs. The company produces superior medicines used favorably by consumers such as Madecassol, which is a drug for wounds and Oramedy, which is a drug for treating stomatitis. It also owns a prefilled syringe system in its second factory, through which it produces various kinds of ultramodern injection agents.

DongKook Pharmaceutical Co (XKRX:086450) Headlines

No Headlines